• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过经验不足的妇科医生进行外部验证评估O-RADS系统在鉴别附件包块良恶性方面的准确性。

Accuracy of O-RADS System in Differentiating Between Benign and Malignant Adnexal Masses Assessed via External Validation by Inexperienced Gynecologists.

作者信息

Buranaworathitikul Peeradech, Wisanumahimachai Veera, Phoblap Natthaphon, Porngasemsart Yosagorn, Rugfoong Waranya, Yotchana Nuttha, Uthaichalanont Pakaporn, Jiampochaman Thunthida, Kunanukulwatana Chayanid, Thiamkaew Atiphoom, Luewan Suchaya, Tantipalakorn Charuwan, Tongsong Theera

机构信息

Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.

出版信息

Cancers (Basel). 2024 Nov 13;16(22):3820. doi: 10.3390/cancers16223820.

DOI:10.3390/cancers16223820
PMID:39594775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11592801/
Abstract

To evaluate the accuracy of the O-RADS system in differentiating between benign and malignant adnexal masses, as assessed by inexperienced gynecologists. Ten gynecologic residents attended a 20 h training course on the O-RADS system conducted by experienced examiners. Following the training, the residents performed ultrasound examinations on patients admitted with adnexal masses under supervision, recording the data in a database that included videos and still images. The senior author later accessed this ultrasound database and presented the cases offline to ten residents for O-RADS rating, with the raters being blinded to the final diagnosis. The efficacy of the O-RADS system by the residents and inter-observer variability were assessed. A total of 201 adnexal masses meeting the inclusion criteria were evaluated, consisting of 136 (67.7%) benign masses and 65 (32.3%) malignant masses. The diagnostic performance of the O-RADS system showed a sensitivity of 90.8% (95% CI: 82.2-96.2%) and a specificity of 86.8% (95% CI: 80.4-91.8%). Inter-observer variability in scoring was analyzed using multi-rater Fleiss Kappa analysis, yielding Kappa indices of 0.642 (95% CI: 0.641-0.643). The false positive rate was primarily due to the misclassification of solid components in classic benign masses as O-RADS-4 or O-RADS-5. The O-RADS system demonstrates high diagnostic performance in distinguishing benign from malignant adnexal masses, even when used by inexperienced examiners. However, the false positive rate remains relatively high, mainly due to the over-interpretation of solid-appearing components in classic benign lesions. Despite this, inter-observer variability among non-expert raters was substantial. Incorporating O-RADS system training into residency programs is beneficial for inexperienced practitioners. This study could be an educational model for gynecologic residency training for other systems of sonographic features.

摘要

为评估由经验不足的妇科医生使用的O-RADS系统在鉴别附件包块良恶性方面的准确性。十名妇科住院医师参加了由经验丰富的检查人员举办的为期20小时的O-RADS系统培训课程。培训结束后,住院医师在监督下对患有附件包块的患者进行超声检查,并将数据记录在一个包含视频和静态图像的数据库中。资深作者随后访问了这个超声数据库,并将病例离线呈现给十名住院医师进行O-RADS分级,评分者对最终诊断不知情。评估了住院医师使用O-RADS系统的效能以及观察者间的变异性。共评估了201个符合纳入标准的附件包块,其中136个(67.7%)为良性包块,65个(32.3%)为恶性包块。O-RADS系统的诊断性能显示敏感性为90.8%(95%可信区间:82.2 - 96.2%),特异性为86.8%(95%可信区间:80.4 - 91.8%)。使用多评分者Fleiss Kappa分析对评分的观察者间变异性进行分析,得出Kappa指数为0.642(95%可信区间:0.641 - 0.643)。假阳性率主要是由于经典良性包块中的实性成分被误分类为O-RADS-4或O-RADS-5。O-RADS系统在鉴别附件包块良恶性方面显示出较高的诊断性能,即使由经验不足的检查人员使用也是如此。然而,假阳性率仍然相对较高,主要是由于对经典良性病变中看似实性的成分过度解读。尽管如此,非专家评分者之间的观察者间变异性很大。将O-RADS系统培训纳入住院医师培训项目对经验不足的从业者有益。本研究可为其他超声特征系统的妇科住院医师培训提供一个教育模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/11592801/6e99cea7a4b3/cancers-16-03820-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/11592801/c0418b920e31/cancers-16-03820-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/11592801/a05530a339ac/cancers-16-03820-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/11592801/6e99cea7a4b3/cancers-16-03820-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/11592801/c0418b920e31/cancers-16-03820-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/11592801/a05530a339ac/cancers-16-03820-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/11592801/6e99cea7a4b3/cancers-16-03820-g003.jpg

相似文献

1
Accuracy of O-RADS System in Differentiating Between Benign and Malignant Adnexal Masses Assessed via External Validation by Inexperienced Gynecologists.通过经验不足的妇科医生进行外部验证评估O-RADS系统在鉴别附件包块良恶性方面的准确性。
Cancers (Basel). 2024 Nov 13;16(22):3820. doi: 10.3390/cancers16223820.
2
Diagnostic Performance of O-RADS US (Version 2019 and Version 2022) Incorporating Acoustic Shadowing by Junior Radiologists: Analyzing 1061 Adnexal Masses.初级放射科医生运用伴有声影的O-RADS US(2019版和2022版)的诊断效能:分析1061例附件包块
J Ultrasound Med. 2025 May;44(5):845-855. doi: 10.1002/jum.16644. Epub 2025 Jan 10.
3
Ovarian-Adnexal Imaging-Reporting and Data System (O-RADS) ultrasound version 2019: a prospective validation and comparison to updated version (v2022) in pathologically confirmed adnexal masses.2019年版卵巢附件影像报告和数据系统(O-RADS)超声:对经病理证实的附件肿块进行前瞻性验证并与更新版本(2022版)进行比较
Eur Radiol. 2025 Jun;35(6):3080-3095. doi: 10.1007/s00330-024-11235-z. Epub 2024 Nov 28.
4
Predictive accuracy and reproducibility of the O-RADS US scoring system among sonologists with different training levels.不同培训水平的超声医师中 O-RADS US 评分系统的预测准确性和可重复性。
Arch Gynecol Obstet. 2023 Aug;308(2):631-637. doi: 10.1007/s00404-022-06752-5. Epub 2022 Aug 22.
5
Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.基于超声的风险模型在区分美国队列中良性和恶性卵巢肿瘤的诊断性能。
JAMA Netw Open. 2023 Jul 3;6(7):e2323289. doi: 10.1001/jamanetworkopen.2023.23289.
6
Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.美国放射学院卵巢-附件报告和数据系统超声(O-RADS US)的验证:对 1054 个附件肿块的分析。
Gynecol Oncol. 2021 Jul;162(1):107-112. doi: 10.1016/j.ygyno.2021.04.031. Epub 2021 May 7.
7
American college of radiology ovarian-adnexal reporting and data system ultrasound (O-RADS): Diagnostic performance and inter-reviewer agreement for ovarian masses in children.美国放射学会卵巢附件报告和数据系统超声检查(O-RADS):儿童卵巢肿块的诊断性能及阅片者间一致性
Front Pediatr. 2023 Mar 8;11:1091735. doi: 10.3389/fped.2023.1091735. eCollection 2023.
8
Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.IOTA简易规则、简易规则风险评估、ADNEX模型和O-RADS在北美女性附件区良恶性病变鉴别中的表现
Ultrasound Obstet Gynecol. 2022 May;59(5):668-676. doi: 10.1002/uog.24777. Epub 2022 Apr 8.
9
O-RADS MRI scoring system: key points for correct application in inexperienced hands.O-RADS MRI评分系统: inexperienced hands正确应用的关键点。 (注:这里“inexperienced hands”字面意思是“无经验的手”,结合语境可能是指缺乏经验的使用者等意思,整体译文可能稍显生硬,但严格按照要求翻译)
Insights Imaging. 2024 Apr 12;15(1):107. doi: 10.1186/s13244-024-01670-3.
10
Diagnostic accuracy of ultrasound classifications - O-RADS US v2022, O-RADS US v2020, and IOTA SR - in distinguishing benign and malignant adnexal masses: Enhanced by combining O-RADS US v2022 with tumor marker HE4.超声分类的诊断准确性——O-RADS US v2022、O-RADS US v2020和IOTA SR——在鉴别附件肿块的良恶性方面:通过将O-RADS US v2022与肿瘤标志物HE4相结合得到增强。
Eur J Radiol. 2024 Dec;181:111824. doi: 10.1016/j.ejrad.2024.111824. Epub 2024 Nov 9.

引用本文的文献

1
Knowledge and application of sonographic scoring models for ovarian cancer management among gynecologists in Saudi Arabia: a cross-sectional study.沙特阿拉伯妇科医生对卵巢癌管理的超声评分模型的知识与应用:一项横断面研究。
PeerJ. 2025 Jul 29;13:e19746. doi: 10.7717/peerj.19746. eCollection 2025.